Isthmus Partners, LLC Biolife Solutions Inc Transaction History

Isthmus Partners, LLC

$815 Million
Q3 2024

A detailed history of Isthmus Partners, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Isthmus Partners, LLC holds 132,047 shares of BLFS stock, worth $2.78 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

132,047

Previous 165,247 20.09%

Holding current value

$2.78 Million

Previous $3.54 Million 6.66%

% of portfolio

0.41%

Previous 0.43%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.19 - $26.52 $637,108 - $880,464	-33,200 Reduced 20.09%	132,047 $3.31 Million
Q2 2024 Aug 06, 2024	BUY	$15.14 - $22.99 $639,892 - $971,672	42,265 Added 34.37%	165,247 $3.54 Million
Q1 2024 May 07, 2024	BUY	$15.35 - $18.82 $704,565 - $863,838	45,900 Added 59.55%	122,982 $2.28 Million
Q4 2023 Feb 12, 2024	BUY	$8.99 - $16.86 $81,134 - $152,161	9,025 Added 13.26%	77,082 $1.25 Million
Q3 2023 Nov 14, 2023	BUY	$10.81 - $22.96 $66,708 - $141,686	6,171 Added 9.97%	68,057 $939,000
Q2 2023 Aug 03, 2023	SELL	$17.19 - $24.34 $2,200 - $3,115	-128 Reduced 0.21%	61,886 $1.37 Million
Q1 2023 May 10, 2023	BUY	$17.67 - $26.07 $25,957 - $38,296	1,469 Added 2.43%	62,014 $1.35 Million
Q4 2022 Feb 10, 2023	BUY	$16.95 - $25.07 $4,135 - $6,117	244 Added 0.4%	60,545 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$14.64 - $26.7 $46,525 - $84,852	3,178 Added 5.56%	60,301 $1.37 Million
Q2 2022 Aug 08, 2022	BUY	$10.54 - $24.2 $60,699 - $139,367	5,759 Added 11.21%	57,123 $789,000
Q1 2022 May 04, 2022	BUY	$20.81 - $37.29 $491,282 - $880,342	23,608 Added 85.06%	51,364 $1.17 Million
Q4 2021 Jan 25, 2022	SELL	$32.99 - $58.55 $1,583 - $2,810	-48 Reduced 0.17%	27,756 $1.03 Million
Q3 2021 Nov 10, 2021	SELL	$42.03 - $60.5 $897,466 - $1.29 Million	-21,353 Reduced 43.44%	27,804 $1.18 Million
Q2 2021 Aug 10, 2021	BUY	$29.51 - $44.62 $767 - $1,160	26 Added 0.05%	49,157 $2.19 Million
Q1 2021 May 17, 2021	SELL	$32.95 - $44.24 $61,550 - $82,640	-1,868 Reduced 3.66%	49,131 $1.77 Million
Q4 2020 Feb 16, 2021	SELL	$27.5 - $45.75 $251,487 - $418,383	-9,145 Reduced 15.21%	50,999 $2.03 Million
Q3 2020 Nov 04, 2020	BUY	$16.04 - $28.94 $49,675 - $89,627	3,097 Added 5.43%	60,144 $1.74 Million
Q2 2020 Aug 10, 2020	BUY	$9.2 - $17.06 $61,014 - $113,141	6,632 Added 13.15%	57,047 $933,000
Q1 2020 May 15, 2020	SELL	$8.36 - $17.03 $25,013 - $50,953	-2,992 Reduced 5.6%	50,415 $479,000
Q4 2019 Feb 07, 2020	BUY	$14.59 - $18.9 $536,912 - $695,520	36,800 Added 221.59%	53,407 $864,000
Q3 2019 Nov 14, 2019	BUY	$15.7 - $20.98 $260,729 - $348,414	16,607 New	16,607 $276,000

Others Institutions Holding BLFS

# of Institutions

199

Shares Held

45.3M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $897M
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Isthmus Partners, LLC with notifications on news.

Account

Isthmus Partners, LLC Biolife Solutions Inc Transaction History